Annick Rousseau

3.5k citations

74 papers · 2.5k indexed · h-index 30

Impact in

Transplantation top 0.1%
- Renal Transplantation Outcomes and Treatments
Pediatrics, Perinatology and Child Health top 1%
- Pharmacological Effects and Toxicity Studies

Papers in

Transplantation 43
- Renal Transplantation Outcomes and Treatments 43
Hepatology 12
- Hepatitis C virus research 8

Co-authors: Pierre Marquet Yannick Le Meur Aurélie Prémaud Jean Debord Franck Saint‐Marcoux Lionel Rostaing Jean‐Baptiste Woillard Nicolas Picard
Journals: Clinical Pharmacokinetics (14 papers)Therapeutic Drug Monitoring (12 papers)Pharmacological Research (5 papers)British Journal of Clinical Pharmacology (4 papers)Transplantation (4 papers)
Partner nations: France Belgium United States

In The Last Decade

Annick Rousseau

72 papers receiving 2.4k citations

Peers

Countries citing papers authored by Annick Rousseau

Since Specialization

Citations

This map shows the geographic impact of Annick Rousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annick Rousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annick Rousseau more than expected).

Fields of papers citing papers by Annick Rousseau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annick Rousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annick Rousseau. The network helps show where Annick Rousseau may publish in the future.

Co-authors

The 25 scholars most cited alongside Annick Rousseau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Annick Rousseau Line = papers co-authored together Annick Rousseau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Validation of the psychometrics properties of a French quality of life questionnaire among a cohort of renal transplant recipients less than one year Quality of Life Research ·Davy Beauger, Dorothée Fruit, Claire Villeneuve, Marie‐Laure Laroche, Élisabeth Jouve, Annick Rousseau, Laurent Boyer, Stéphanie Gentile	2016	1
2	Anti-hepatitis C virus drugs and kidney World Journal of Hepatology ·Paul Carrier, Marie Essig, Marilyne Debette‐Gratien, Denis Sautereau, Annick Rousseau, Pierre Marquet, Jérémie Jacques, V. Loustaud‐Ratti	2016	17
3	Exposure to Mycophenolic Acid Better Predicts Immunosuppressive Efficacy Than Exposure to Calcineurin Inhibitors in Renal Transplant Patients Clinical Pharmacology & Therapeutics ·Zeinab Abdi, Aurélie Prémaud, Marie Essig, Sophie Alain, E Munteanu, Fabien Garnier, Yannick Le Meur, Pierre Marquet, Annick Rousseau	2014	33
4	Pharmacological exposure to ribavirin: A key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment Digestive and Liver Disease ·V. Loustaud‐Ratti, Paul Carrier, Annick Rousseau, Marianne Maynard, G Babany, Sophie Alain, C. Trépo, Victor de Lédinghen, Marc Bourlière, Stanislas Pol, Vincent Di Martino, Jean‐Pierre Zarski, Alexandrina Pinta, Denis Sautereau, Pierre Marquet	2011	12
5	Stability of Ribavirin Concentrations Depending on the Type of Blood Collection Tube and Preanalytical Conditions Therapeutic Drug Monitoring ·Pierre Marquet, François‐Ludovic Sauvage, V. Loustaud‐Ratti, G Babany, Annick Rousseau, Gérard Lachâtre	2010	9
6	Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches Pharmacological Research ·Aurélie Prémaud, L. T. Weber, Burkhard Tönshoff, Victor W. Armstrong, Michael Oellerich, Saı̈k Urien, Pierre Marquet, Annick Rousseau	2010	35
7	Limited Sampling Models and Bayesian Estimation for Mycophenolic Acid Area under the Curve Prediction in Stable Renal Transplant Patients Co-Medicated with Ciclosporin or Sirolimus Clinical Pharmacokinetics ·Flora T. Musuamba, Annick Rousseau, Jean‐Louis Bosmans, Jean-Jacques Senessael, Jean Cumps, Pierre Marquet, Pierre Wallemacq, Roger K. Verbeeck	2009	46
8	Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation American Journal of Transplantation ·Yannick Le Meur, M. Büchler, Antoine Thierry, Sophie Caillard, F. Villemain, S. Lavaud, Isabelle Étienne, P.F. Westeel, Bruno Hurault de Ligny, Lionel Rostaing, Éric Thervet, Jean-Christophe Szelag, Jean-Philippe Rérolle, Annick Rousseau, Guy Touchard, Pierre Marquet	2007	321
9	Population Pharmacokinetics and Bayesian Estimator of Cyclosporine in Pediatric Renal Transplant Patients Therapeutic Drug Monitoring ·Sabine Irtan, Franck Saint‐Marcoux, Annick Rousseau, D Zhang, Valériane Leroy, Pierre Marquet, Évelyne Jacqz-Aigrain	2007	34
10	Patient Characteristics Influencing Ciclosporin Pharmacokinetics and Accurate Bayesian Estimation of Ciclosporin Exposure in Heart, Lung and Kidney Transplant Patients Clinical Pharmacokinetics ·Franck Saint‐Marcoux, Pierre Marquet, Évelyne Jacqz-Aigrain, Nicole F. Bernard, Philippe Thiry, Yannick Le Meur, Annick Rousseau	2006	29
11	Tacrolimus Pharmacokinetics and Dose Monitoring After Lung Transplantation for Cystic Fibrosis and Other Conditions American Journal of Transplantation ·Christiane Knoop, Philippe Thiry, Franck Saint‐Marcoux, Annick Rousseau, Pierre Marquet, Marc Estenne	2005	39
12	Population Pharmacokinetic Modeling of Oral Cyclosporin Using NONMEM Therapeutic Drug Monitoring ·Annick Rousseau, F. Léger, Yannick Le Meur, Franck Saint‐Marcoux, Gilles Paintaud, M. Büchler, Pierre Marquet	2004	75
13	Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC0–12 monitoring in cardiac transplant recipients over the first year post-transplantation European Journal of Clinical Pharmacology ·Caroline Monchaud, Annick Rousseau, F. Léger, Olivier J. David, Jean Debord, Thierry Dantoine, Pierre Marquet	2003	27
14	An Animal Model for the Study of Chronopharmacokinetics of Drugs and Application to Methotrexate and Vinorelbine Toxicology and Applied Pharmacology ·Aurélie Prémaud, Annick Rousseau, M Gicquel, Sylvie Ragot, Jacqueline Manceau, Michel Laurentie, Pierre Marquet	2002	9
15	Maximum A Posteriori Bayesian Estimation of Oral Cyclosporin Pharmacokinetics in Patients with Stable Renal Transplants Clinical Pharmacokinetics ·F. Léger, Jean Debord, Yannick Le Meur, Annick Rousseau, Mathias B chler, (unknown), Gilles Paintaud, Pierre Marquet	2002	47
16	Adaptive Control Methods for the Dose Individualisation of Anticancer Agents Clinical Pharmacokinetics ·Annick Rousseau, Pierre Marquet, Jean Debord, Christophe Sabot, (unknown)	2000	44
17	Relationship between Psychotropic Drugs and Thyroid Function: A Review Toxicology and Applied Pharmacology ·Marie-Frédérique Sauvage, Pierre Marquet, Annick Rousseau, C Raby, Jacques Buxeraud, Gérard Lachâtre	1998	37
18	Anti-Inflammatory Action of Methimazole Pharmacology ·Jean F. Lagorce, T Moulard, Annick Rousseau, Francis Comby, Jacques Buxeraud, C Raby	1997	12
19	Sensitive microanalysis of imipramine and desipramine in single rat thyroids by gas chromatography–mass spectrometry Journal of Chromatography B Biomedical Sciences and Applications ·Annick Rousseau, Pierre Marquet, Francis Comby, Jacques Buxeraud, C Raby, Gérard Lachâtre	1997	4
20	Synthesis and Antithyroid Activity of Pyridine, Pyrimidine and Pyrazine Derivatives of Thiazole-2-thiol and 2-Thiazoline-2-thiol. Chemical and Pharmaceutical Bulletin ·Jean-François Lagorce, Francis Comby, Annick Rousseau, Jacques Buxeraud, C Raby	1993	13

About Annick Rousseau

Annick Rousseau is a scholar working on Transplantation, Hepatology, Nephrology, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health, having authored 74 papers that have together received 2.5k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (43 papers), Pharmacological Effects and Toxicity Studies (13 papers), Transplantation: Methods and Outcomes (9 papers), Hepatitis C virus research (8 papers), HIV/AIDS drug development and treatment (8 papers), Neurological Complications and Syndromes (7 papers), Drug Transport and Resistance Mechanisms (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). The work is most often cited by research in Transplantation (1.6k citations), Pediatrics, Perinatology and Child Health (694 citations), Hepatology (225 citations), Psychiatry and Mental health (393 citations) and Nephrology (172 citations). Annick Rousseau has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Pierre Marquet, Yannick Le Meur, Aurélie Prémaud, Jean Debord, Franck Saint‐Marcoux, Lionel Rostaing, Jean‐Baptiste Woillard, Nicolas Picard, Jean-Philippe Rérolle and Guillaume Hoizey. Their work appears in journals such as Clinical Pharmacokinetics, Therapeutic Drug Monitoring, Pharmacological Research, British Journal of Clinical Pharmacology and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact